101001-54-1 Usage
Molecular structure
2-[1-(2-ethoxyethyl)-1H-pyrrol-2-yl]-4,5-bis(4-methoxyphenyl)-1,3-thiazole is a complex organic compound with a heterocyclic structure.
Thiazole ring
A five-membered heterocyclic ring containing sulfur and nitrogen atoms.
Pyrrole ring
A five-membered heterocyclic ring containing nitrogen atoms.
Ethoxyethyl groups
Two ethoxyethyl groups are present in the compound, indicating a potential for pharmacological or biological activity.
Methoxyphenyl groups
The presence of two methoxyphenyl groups also suggests potential pharmacological or biological activity.
Potential applications
The compound may have potential applications in the field of pharmacology or biology due to its heterocyclic structure and functional groups.
Specific chemical structure
The precise properties and potential applications of this compound would depend on its specific chemical structure and the context in which it is used.
Check Digit Verification of cas no
The CAS Registry Mumber 101001-54-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,0,0 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 101001-54:
(8*1)+(7*0)+(6*1)+(5*0)+(4*0)+(3*1)+(2*5)+(1*4)=31
31 % 10 = 1
So 101001-54-1 is a valid CAS Registry Number.
101001-54-1Relevant articles and documents
Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same
-
, (2008/06/13)
Novel 4,5-bis(4-methoxyphenyl)-2-(pyrrol-2-yl)-thiazoles of the formula: STR1 wherein R1 is C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, 2,2,2-trifluoroethyl, a group of the formula: --CH2 COOR2 R2 is C1-8 alkyl, C2-4 alkenyl, C2-4 alkynyl, or phenyl-C1-2 alkyl), or a group of the formula: --(CH2)n --A--R3 (A is oxygen or sulfur, R3 is C1-4 alkyl or C2-4 alkenyl, and n is 1, 2 or 3), a process for the preparation of the compounds, and a pharmaceutical composition useful as a platelet aggregation inhibitor which comprises as an active ingredient the above 4,5-bis(4-methoxyphenyl)-2-(pyrrol-2-yl)thiazole compound in admixture with a conventional pharmaceutically acceptable carrier or diluent.
